A cytotoxic anti-HLA-AB monoclonal antibody which in dilution becomes specific to HLA-A3 crossreacting group. 1984

M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini

XI 20.4 monoclonal antibody belongs to the IgM class. It precipitates two polypeptide chains characteristic of HLA Class I antigens. At the highest dilutions it is cytotoxic against lymphocytes carrying antigens of the HLA-A3 crossreacting group. Lysostrip experiments show that, at the lowest dilutions, the antibody reacts either with HLA-A, or B antigens.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell

Related Publications

M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini
January 1982, Hybridoma,
M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini
November 1982, Immunology letters,
M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini
June 1990, Nihon hoigaku zasshi = The Japanese journal of legal medicine,
M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini
February 1982, Tissue antigens,
M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini
January 1985, Human immunology,
M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini
August 1980, The Journal of experimental medicine,
M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini
October 1990, Hybridoma,
M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini
March 1993, Human immunology,
M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini
November 1984, Tissue antigens,
M C Mazzilli, and I Cascino, and S C Porrini, and M V Lavaggi, and P Lulli, and M Morellini, and L Testa, and E Gandini
November 1979, Tissue antigens,
Copied contents to your clipboard!